Novel Models of Streptococcus Canis Colonization and Disease Reveal Modest Contributions of M-Like (SCM) Protein
Total Page:16
File Type:pdf, Size:1020Kb
microorganisms Article Novel Models of Streptococcus canis Colonization and Disease Reveal Modest Contributions of M-Like (SCM) Protein Ingrid Cornax 1,†,‡, Jacob Zulk 2,† , Joshua Olson 1, Marcus Fulde 3, Victor Nizet 1,4 and Kathryn A Patras 2,* 1 Department of Pediatrics, UC San Diego, La Jolla, CA 92093, USA; [email protected] (I.C.); [email protected] (J.O.); [email protected] (V.N.) 2 Department of Molecular Virology and Microbiology, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA; [email protected] 3 Institute of Microbiology and Epizootics, Centre of Infection Medicine, Freie Universität Berlin, 14163 Berlin, Germany; [email protected] 4 Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego, La Jolla, CA 92093, USA * Correspondence: [email protected] † These authors contributed equally to this work. ‡ Present address: Janssen Research & Development, LLC, La Jolla, CA 92121, USA. Abstract: Streptococcus canis is a common colonizing bacterium of the urogenital tract of cats and dogs that can also cause invasive disease in these animal populations and in humans. Although the virulence mechanisms of S. canis are not well-characterized, an M-like protein, SCM, has recently identified been as a potential virulence factor. SCM is a surface-associated protein that binds to host plasminogen and IgGs suggesting its possible importance in host-pathogen interactions. In this study, we developed in vitro and ex vivo blood component models and murine models of S. canis vaginal colonization, systemic infection, and dermal infection to compare the virulence potential of the zoonotic S. canis vaginal isolate G361 and its isogenic SCM-deficient mutant (G361Dscm). We found that while S. canis establishes vaginal colonization and causes invasive disease in vivo, the contribution of the SCM protein to virulence phenotypes in these models is modest. We conclude Citation: Cornax, I.; Zulk, J.; Olson, that SCM is dispensable for invasive disease in murine models and for resistance to human blood J.; Fulde, M.; Nizet, V.; Patras, K.A. components ex vivo, but may contribute to mucosal persistence, highlighting a potential contribution Novel Models of Streptococcus canis to the recently appreciated genetic diversity of SCM across strains and hosts. Colonization and Disease Reveal Modest Contributions of M-Like Keywords: Streptococcus canis; M protein; virulence factor; innate immunity; vaginal colonization (SCM) Protein. Microorganisms 2021, 9, 183. https://doi.org/10.3390/ microorganisms9010183 1. Introduction Received: 7 January 2021 Accepted: 14 January 2021 Streptococcus canis is a Gram-positive beta-hemolytic group G Streptococcus that col- Published: 16 January 2021 onizes the epithelial, respiratory, gastrointestinal, and urogenital surfaces of cats and dogs [1–3]. Officially named a species in 1986, S. canis is well-recognized in veterinary Publisher’s Note: MDPI stays neu- medicine for causing a variety of invasive diseases across domestic animal species including tral with regard to jurisdictional clai- sepsis, necrotizing fasciitis, urinary tract infection, ulcerative keratitis, and mastitis [4–9]. ms in published maps and institutio- Similar S. canis colonization and disease manifestations have been reported in wild animal nal affiliations. populations [10–12]. Since its first description as a zoonotic agent in 1996 [13], human cases of S. canis-mediated endocarditis, septicemia, cellulitis, and periprosthetic joint infection have been reported [14–21]. A retrospective study identified S. canis as the causative agent in ~1% of human streptococcal infections, however, given the reliance of Lancefield classi- Copyright: © 2021 by the authors. Li- Streptococcus censee MDPI, Basel, Switzerland. fication for group G identification without further speciation, coupled with This article is an open access article close interactions between humans and companion animals, it is likely that S. canis human distributed under the terms and con- infections are underestimated [22,23]. ditions of the Creative Commons At- The genetic diversity and molecular pathogenesis of S. canis is being actively explored. tribution (CC BY) license (https:// There are currently more than 50 multi-locus sequence types (MLST) and 20 genomes for creativecommons.org/licenses/by/ S. canis [23,24]. The host immune response to S. canis is not well-described, yet the pyogenic 4.0/). nature of many S. canis soft tissue infections suggest neutrophils and macrophages may Microorganisms 2021, 9, 183. https://doi.org/10.3390/microorganisms9010183 https://www.mdpi.com/journal/microorganisms Microorganisms 2021, 9, 183 2 of 16 be involved. To date, knowledge of S. canis virulence factors remains limited, and is largely extrapolated from genetic similarities to the widely-studied group A Streptococcus (S. pyogenes)[12]. Similar to S. pyogenes, S. canis possesses an arginine deiminase system [25], a streptolysin O orthologue [26], lysogenic bacteriophage [27], and an M-like protein termed SCM (or SPASc) [28], which is currently the best characterized among candidate S. canis virulence factors [29]. In S. pyogenes, the M protein, which is genetically diverse with more than 200 emm types, serves multiple roles in pathogenesis and immune evasion [30]. Likewise, S. canis SCM displays genetic heterogeneity. There are currently 15 SCM types divided into group I and II alleles [23]. SCM is a fibrillar surface protein [26] which binds plasminogen [29] and the Fc region of IgGs from multiple species including human, dog, cat, and mouse [31]. We recently demonstrated that SCM self-interactions facilitate bacterial aggregation and that SCM interactions with IgG initiate formation of protein complexes in human plasma [32]. However, the contribution of SCM, and impact of its allelic variability, to S. canis coloniza- tion and virulence remains undefined. In this study, we incorporated in vitro and ex vivo human blood component models, together with murine models of S. canis vaginal colonization, systemic infection, and dermal infection to broadly characterize the virulence potential of the zoonotic S. canis vaginal isolate G361, originally isolated from a 40-year-old female, and its isogenic SCM-deficient mutant (G361Dscm). 2. Materials and Methods 2.1. Bacterial Strains, Growth Conditions, and In Vitro Phenotyping Assays Bacterial strains used in this study include Streptococcus canis human vaginal wild- type (WT) isolate G361 [33] and isogenic scm-targeted insertional mutant G361Dscm [32], Streptococcus pyogenes human invasive isolate 5448 M1 and isogenic Demm1 [34], and Streptococcus agalactiae human meningeal isolate COH1 (ATCC BAA-1176). All bacterial strains were grown to stationary phase in Todd-Hewitt broth (THB, Hardy Diagnostics), or THB agar plates, at 37 ◦C without shaking. Erythromycin (5 µg/mL) was added to G361Dscm to retain the plasmid insertion. Cultures were diluted in fresh THB and incu- ◦ bated at 37 C until mid-logarithmic phase (defined as OD600 = 0.4). For growth curves, stationary cultures were diluted to OD600 = 0.1 in either fresh THB or RPMI-1640 (Gibco) and incubated at 37 ◦C for 3 h with optical density measured every 30 min. To assess hemolytic activity, WT G361 and G361Dscm were grown overnight and 10 µL was spot- ted onto blood agar plates (TSA with 5% sheep blood, Thermo Scientific) and incubated ◦ for 24 h at 37 C with 5% CO2. For minimum inhibitory concentrations (MIC), mid-log phase S. canis was diluted 1:100 in THB and 100 µL was added to 96-well microtiter plates. Hydrogen peroxide or hypochlorite (1.5-fold dilution series, final concentrations tested 0–3.5 mM and 0–0.34 mM respectively) was diluted in THB and 100 µL was added to the ◦ bacterial plates (200 µL total). The plates were then incubated at 37 C for 18 h and OD600 was measured to determine MIC values (calculated as 90% reduction in OD600 from S. canis only controls). 2.2. Biofilm Formation S. canis and S. pyogenes biofilms were assessed using methods adapted from previous work [35]. Briefly, stationary cultures were diluted in THB or RPMI-1640 to OD600 = 0.1, and 200 µL added to tissue culture-treated 96-well plates. Biofilms were allowed to form for 48 h at 37 ◦C without shaking. After washing 3X with PBS, biofilms were stained with 1µM SYTO 13 nucleic acid stain (Invitrogen) for 30 min in the dark. Biofilms were then washed 3X with PBS and quantified by measuring fluorescence at OD485/OD520 on an Infinite 200 Pro (Tecan) plate reader. Fluorescent images of biofilms were also collected using an Echo Revolve microscope at 100X magnification. Microorganisms 2021, 9, 183 3 of 16 2.3. Mammalian Cell Lines and Growth Conditions Canine macrophage-like cells (DH82), immortalized human vaginal epithelial cells (VK2/E6E7), and human monocyte cell line (THP-1) were acquired from the American Type Culture Collection (ATCC CRL-10389, ATCC CRL-2616, and ATCC TIB-202 respec- tively). HEK-Blue IL-1β cells (Cat# hkb-il1b) were purchased from InvivoGen. DH82 cells were cultured in Eagle’s Minimum Essential Medium (EMEM) (Gibco) + 15% FBS (heat inactivated). VK2 cells were cultured in keratinocyte serum-free medium (KSFM) (Gibco) with 0.5 ng/mL human recombinant epidermal growth factor and 0.05 mg/mL bovine pituitary extract. THP-1 cells were grown in suspension in the following media: RPMI-1640 (Gibco) + 10% FBS (heat inactivated) + 10 mM HEPES + 1 mM sodium pyruvate + 4500 mg/L glucose + 1500 µg/mL sodium bicarbonate + 0.05 mM 2-mercaptoethanol. When macrophage differentiation was necessary, the cells were treated for 24 h with 25 nM phorbol myristate acetate (PMA) to produce an adherent culture. HEK-Blue IL-1β cells were grown in adherent culture in Dulbecco’s Modified Eagle Medium (DMEM) with L-glutamine (Gibco) + 10% FBS (heat inactivated) + 200 µg/mL HygromycinB (InvivoGen) ◦ + 100 µg/mL Zeocin (Invitrogen). All cells were cultured in a 37 C incubator with 5% CO2. Adherent cells were split every 3–4 days at ~80% confluency, and 0.25% trypsin/2.21mM EDTA (Corning) were used to detach DH82 and VK2 cells for passaging.